Kaliumiodid

Potassium Iodide, the active ingredient in Kaliumiodid, is an iodine supplement presented as an oral preparation for use in radiation emergencies and thyroid protection. It supplies stable iodine to help block thyroid uptake of radioactive iodine and to address iodine deficiency in at‑risk populations.

GNH USA supplies Kaliumiodid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global health programs. Customers benefit from comprehensive regulatory support and timely delivery across diverse markets.

Potassium Iodide is used to manage iodine‑related conditions and protect the thyroid from radioactive iodine exposure. Radiation emergency prophylaxis: Provides stable iodine to block thyroid uptake of radioactive iodine, reducing radiation dose to the gland. Thyroid protection: Supplies iodine to saturate the thyroid, preventing absorption of harmful isotopes during nuclear incidents. Iodine deficiency: Supplements dietary iodine to support normal thyroid hormone synthesis in populations with insufficient iodine intake.

Potassium Iodide may cause a range of adverse reactions, most of which are mild and transient. Common Side Effects: - Taste alteration: Metallic or salty taste in the mouth. - Gastrointestinal discomfort: Nausea, vomiting or abdominal cramps. - Mild rash: Skin irritation or itching at the site of contact. - Salivation increase: Excessive saliva production. Serious or Rare Side Effects: - Allergic reaction: Hives, swelling, or anaphylaxis requiring immediate medical attention. - Thyrotoxicosis: Excessive thyroid hormone release in susceptible individuals. - Hypersensitivity pneumonitis: Rare lung inflammation after inhalation of powdered forms.

When using Potassium Iodide, certain precautions should be observed to ensure safety and effectiveness. - Pregnancy: Use only if clearly needed, as excess iodine may affect fetal thyroid. - Breastfeeding: Caution advised; monitor infant for thyroid dysfunction. - Renal impairment: Adjust dose or monitor iodine levels due to reduced excretion. - Thyroid disease: Patients with hyperthyroidism may experience exacerbation. - Drug interactions: Avoid concurrent use with antithyroid medications without supervision. - Store below 25°C: Keep in the original pack, protect from moisture.

Potassium Iodide can interact with other medicines, requiring attention to avoid reduced efficacy or increased risk. Major Interactions (Avoid): - Antithyroid drugs (e.g., propylthiouracil, methimazole): May reduce the protective effect of potassium iodide. - Radioactive iodine therapy: Potassium iodide can interfere with intended uptake of therapeutic I‑131. - Amiodarone: High iodine content may lead to excess iodine load. Moderate Interactions (Monitor Closely): - Lithium: May increase risk of thyroid dysfunction when combined with excess iodine. - ACE inhibitors: Potential for altered renal handling of iodine; monitor renal function. - Thiazide diuretics: May affect iodine excretion, watch for accumulation.